Brivudine clinical trials
Also written RP101.
How each study uses brivudine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the brivudine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2019 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Redwood Pharma AB (1) · Peking University Third Hospital (1) · SciClone Pharmaceuticals (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test brivudine.
- Dec 2026Efficacy and Safety of Brivudine in the Treatment of Herpes ZosterPhase 4 · Peking University Third Hospital
Studies
Open first, then newest update. How each study uses brivudine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety of Brivudine in the Treatment of Herpes ZosterRecruitingPhase 4Peking University Third HospitalNCT07099157Written as Brivudine
- Effects of RP101 in Post-menopausal Women With Dry Eye SyndromeCompletedPhase 2Redwood Pharma ABNCT03821415Written as RP101
- Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With GemcitabineTerminatedPhase 2SciClone PharmaceuticalsNCT00550004Written as RP101
Codes
What other systems call brivudine · ClinicalTrials.gg INT002716
- MeSH (NLM) C020235brivudineConfirmed NLM, Wikidata
- UNII (FDA) 2M3055079HBRIVUDINEConfirmed FDA, NLM, Wikidata
- RxNorm 59161Confirmed FDA, Wikidata
- Wikidata Q904107brivudineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C67088BrivudineOne source FDA
- DrugBank DB03312One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C020235 | brivudine | Confirmed NLM, Wikidata |
| UNII (FDA) | 2M3055079H | BRIVUDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 59161 | — | Confirmed FDA, Wikidata |
| Wikidata | Q904107 | brivudine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C67088 | Brivudine | One source FDA |
| DrugBank | DB03312 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.